Q2 2024 |
29 |
$157M |
+$15.9M |
-$15.7M |
+$238K |
BFH, T, JXN, LNC, WAL
|
13F-HR |
8/13/2024, 04:18 PM |
Q1 2024 |
30 |
$156M |
+$27.3M |
-$56.6M |
-$29.2M |
STLA, T, JXN, BFH, WAL
|
13F-HR |
5/7/2024, 11:23 AM |
Q4 2023 |
42 |
$168M |
+$12.6M |
-$25M |
-$12.4M |
STLA, WAL, UPRO, JXN, BFH
|
13F-HR |
2/14/2024, 01:24 PM |
Q3 2023 |
50 |
$159M |
+$27.2M |
-$24.7M |
+$2.48M |
STLA, JXN, WAL, QUAD, T
|
13F-HR |
11/14/2023, 03:00 PM |
Q2 2023 |
94 |
$152M |
+$22.9M |
-$1.48B |
-$1.46B |
UPRO, STLA, VTRS, OMF, CTO
|
13F-HR |
8/14/2023, 03:33 PM |
Q1 2023 |
90 |
$1.6B |
+$107M |
-$134M |
-$26.9M |
OMF, EXPE, AMZN, TMHC, GOOGL
|
13F-HR |
5/15/2023, 01:04 PM |
Q4 2022 |
84 |
$1.55B |
+$153M |
-$214M |
-$61.2M |
OVV, OMF, EXPE, TMHC, MAT
|
Restatement |
2/14/2023, 01:39 PM |
Q3 2022 |
91 |
$1.64B |
+$184M |
-$165M |
+$19.5M |
OVV, AMZN, EXPE, TEVA, MAT
|
13F-HR |
11/14/2022, 12:00 PM |
Q2 2022 |
118 |
$1.97B |
+$250M |
-$415M |
-$166M |
TLT, BABA, OVV, MAT, DXC
|
13F-HR |
8/15/2022, 01:05 PM |
Q1 2022 |
125 |
$3.11B |
+$238M |
-$467M |
-$229M |
TLT, AMZN, OVV, JD, NCLH
|
13F-HR |
5/16/2022, 12:01 PM |
Q4 2021 |
127 |
$3.65B |
+$816M |
-$417M |
+$399M |
TLT, AMZN, JD, AMZN, DXC
|
13F-HR |
2/14/2022, 12:08 PM |
Q3 2021 |
96 |
$2.94B |
+$248M |
-$655M |
-$407M |
AMZN, DXC, SPLK, GOOGL, META
|
13F-HR |
11/15/2021, 02:16 PM |
Q2 2021 |
100 |
$3.84B |
+$459M |
-$325M |
+$133M |
DXC, ADT, AMZN, BABA, OMF
|
13F-HR |
8/16/2021, 02:12 PM |
Q1 2021 |
94 |
$3.52B |
+$482M |
-$280M |
+$202M |
DXC, OMF, FTCHF, TEVA, AMZN
|
13F-HR |
5/17/2021, 12:00 PM |
Q4 2020 |
102 |
$3.28B |
+$502M |
-$600M |
-$98.3M |
UBER, FTCH, DXC, AMZN, DM
|
13F-HR |
2/16/2021, 01:08 PM |
Q3 2020 |
89 |
$2.79B |
+$631M |
-$334M |
+$298M |
UBER, FTCH, AMZN, ADT, BABA
|
13F-HR |
11/16/2020, 09:51 AM |
Q2 2020 |
79 |
$2.25B |
+$262M |
-$196M |
+$66M |
FTCH, AMZN, ADT, TEVA, META
|
13F-HR |
8/14/2020, 02:35 PM |
Q1 2020 |
73 |
$1.55B |
+$335M |
-$198M |
+$137M |
AMZN, TEVA, ADT, FTCH, BABA
|
13F-HR |
5/15/2020, 11:02 AM |
Q4 2019 |
95 |
$2.82B |
+$229M |
-$217M |
+$12.2M |
ADT, BHC, AMZN, OMF, FLXN
|
13F-HR |
2/14/2020, 11:05 AM |
Q3 2019 |
101 |
$2.49B |
+$245M |
-$220M |
+$24.8M |
RH, AMZN, ADT, OMF, BHC
|
13F-HR |
11/14/2019, 08:13 AM |
Q2 2019 |
100 |
$2.53B |
+$259M |
-$181M |
+$78M |
AMZN, BHC, RH, OMF, ADT
|
13F-HR |
8/14/2019, 10:38 AM |
Q1 2019 |
101 |
$2.52B |
+$207M |
-$114M |
+$93M |
AMZN, BHC, OMF, RH, BHF
|
13F-HR |
5/15/2019, 01:29 PM |
Q4 2018 |
102 |
$2.2B |
+$92.3M |
-$167M |
-$74.9M |
AMZN, RH, GNW, BHC, OMF
|
13F-HR |
2/14/2019, 08:39 AM |
Q3 2018 |
109 |
$3.09B |
+$671M |
-$128M |
+$543M |
AMZN, ENDPQ, RH, BHC, OMF
|
13F-HR |
11/14/2018, 10:15 AM |
Q2 2018 |
111 |
$2.68B |
+$206M |
-$158M |
+$47.9M |
AMZN, RH, VRX, OMF, GNW
|
Restatement |
8/15/2018, 01:40 PM |
Q1 2018 |
110 |
$2.4B |
+$196M |
-$152M |
+$43.8M |
AMZN, RH, OMF, VRX, DAL
|
13F-HR |
5/15/2018, 11:42 AM |
Q4 2017 |
107 |
$2.31B |
+$227M |
-$122M |
+$105M |
VRX, AMZN, RH, OMF, DAL
|
13F-HR |
2/14/2018, 09:41 AM |
Q3 2017 |
113 |
$2.32B |
+$179M |
-$272M |
-$92.8M |
AMZN, RH, OMF, VRX, AAPL
|
13F-HR |
11/14/2017, 01:28 PM |
Q2 2017 |
116 |
$2.47B |
+$165M |
-$182M |
-$17.1M |
AAPL, RH, VRX, AMZN, PAH
|
13F-HR |
8/14/2017, 10:06 AM |
Q1 2017 |
70 |
$2.27B |
+$398M |
-$313M |
+$85.1M |
AAPL, RH, AMZN, PAH, OMF
|
13F-HR |
5/12/2017, 02:35 PM |
Q4 2016 |
59 |
$2.28B |
+$291M |
-$149M |
+$142M |
AAPL, UAL, DAL, AAL, AMZN
|
13F-HR |
2/14/2017, 01:44 PM |
Q3 2016 |
64 |
$2.44B |
+$21.3M |
-$176M |
-$155M |
AAPL, AMZN, OMF, XON, QUOT
|
13F-HR |
11/14/2016, 11:08 AM |
Q2 2016 |
65 |
$2.24B |
+$264M |
-$394M |
-$130M |
AAPL, AMZN, QUOT, LEN, PHM
|
13F-HR |
8/15/2016, 11:52 AM |
Q1 2016 |
70 |
$2.6B |
+$183M |
-$617M |
-$433M |
AMZN, AAPL, DAL, XON, UAL
|
13F-HR |
5/16/2016, 11:51 AM |
Q4 2015 |
82 |
$3.74B |
+$413M |
-$140M |
+$274M |
AMZN, AAPL, TWTR, DAL, AAL
|
13F-HR |
2/16/2016, 09:35 AM |
Q3 2015 |
83 |
$3.48B |
+$479M |
-$76.9M |
+$402M |
AMZN, AAPL, TWTR, DAL, P
|
Restatement |
11/17/2015, 10:05 AM |
Q2 2015 |
87 |
$2.64B |
+$78.2M |
-$66.4M |
+$11.8M |
XON, MTG, DAL, AAL, NXPI
|
13F-HR |
8/14/2015, 10:43 AM |
Q1 2015 |
91 |
$2.65B |
+$194M |
-$190M |
+$4.46M |
XON, AAL, UAL, DAL, FCAU
|
13F-HR |
5/15/2015, 12:48 PM |
Q4 2014 |
94 |
$2.55B |
+$485M |
-$154M |
+$331M |
AAL, DAL, UAL, GNW, PHM
|
13F-HR |
2/17/2015, 12:00 PM |
Q3 2014 |
113 |
$2.36B |
+$231M |
-$3.25M |
+$228M |
DAL, UAL, AAL, QCOM, GILD
|
13F-HR |
11/14/2014, 09:00 AM |
Q2 2014 |
113 |
$2.49B |
+$205M |
-$146M |
+$59.4M |
AAL, DAL, GNW, QCOM, MTG
|
13F-HR |
8/14/2014, 02:10 PM |
Q1 2014 |
110 |
$2.49B |
+$335M |
-$33.9M |
+$301M |
GNW, DAL, AAL, NRFXXXX, QCOM
|
13F-HR |
5/15/2014, 01:44 PM |
Q4 2013 |
104 |
$2.15B |
|
|
|
GNW, MTG, DAL, NRFXXXX, NCTXXXX
|
13F-HR |
2/14/2014, 12:38 PM |